Is Procter & Gamble stock a Buy, Sell or Hold?
Procter & Gamble stock has received a consensus rating of buy. The average rating score is Aa3 and is based on 24 buy ratings, 9 hold ratings, and 0 sell ratings.What was the 52-week low for Procter & Gamble stock?
The low in the last 52 weeks of Procter & Gamble stock was 129.50. According to the current price, Procter & Gamble is 112.60% away from the 52-week low.What was the 52-week high for Procter & Gamble stock?
The high in the last 52 weeks of Procter & Gamble stock was 165.31. According to the current price, Procter & Gamble is 88.21% away from the 52-week high.What are analysts forecasts for Procter & Gamble stock?
The 33 analysts offering price forecasts for Procter & Gamble have a median target of 161.64, with a high estimate of 180.00 and a low estimate of 138.00. The median estimate represents a 90.21 difference from the last price of 145.82.Procter & Gamble News More News
Procter & Gamble Historical Prices
Date | Open | Close | Daily High | Daily Low |
---|
Price change over selected period:
0%
0
Procter & Gamble Analyst Data
Total Analysts: 33
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 138.00
Median: 161.64
Highest: 180.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Procter & Gamble Analyst Opinions
- All
- Buy
- Hold
- Sell
08/02/22 | Barclays Capital | Maintained Buy | $154 | ||
07/25/22 | Raymond James Financial, Inc. | Maintained Buy | $175 | ||
07/21/22 | J.P. Morgan | Maintained Hold | $156 | ||
06/21/22 | Deutsche Bank | Maintained Buy | $157 | ||
06/01/22 | Deutsche Bank | Maintained Buy | $171 | ||
06/01/22 | Wells Fargo & Co | Maintained Buy | $170 | ||
05/23/22 | Barclays Capital | Maintained Buy | $157 | ||
04/22/22 | Barclays Capital | Maintained Buy | $176 | ||
04/21/22 | Deutsche Bank | Maintained Buy | $177 | ||
04/21/22 | Raymond James Financial, Inc. | Maintained Buy | $180 | ||
04/21/22 | Credit Suisse | Maintained Hold | $150 | ||
04/08/22 | Raymond James Financial, Inc. | Maintained Buy | $175 | ||
04/01/22 | Barclays Capital | Maintained Buy | $167 | ||
03/30/22 | J.P. Morgan | Downgraded to Hold | $165 | ||
03/16/22 | Deutsche Bank | Maintained Buy | $173 | ||
01/20/22 | RBC Capital Markets | Maintained Hold | $160 | ||
01/20/22 | Deutsche Bank | Maintained Buy | $179 | ||
01/20/22 | Morgan Stanley | Maintained Buy | $177 | ||
10/04/21 | Deutsche Bank | Maintained Buy | $163 | ||
09/07/21 | Morgan Stanley | Maintained Buy | $161 | ||
08/02/21 | Morgan Stanley | Maintained Buy | $160 | ||
08/02/21 | RBC Capital Markets | Maintained Hold | $139 | ||
08/02/21 | Credit Suisse | Maintained Hold | $145 | ||
06/24/21 | UBS | Maintained Hold | $138 | ||
04/21/21 | Deutsche Bank | Maintained Buy | $158 | ||
04/21/21 | Citigroup Corp. | Downgraded to Hold | $150 | ||
04/19/21 | Morgan Stanley | Maintained Buy | $155 | ||
04/16/21 | J.P. Morgan | Maintained Buy | $148 | ||
01/28/21 | Stifel, Nicolaus & Co., Inc. | Downgraded to Buy | |||
01/20/21 | Bernstein | Maintained Hold | $149 | ||
12/08/20 | Wells Fargo & Co | Maintained Buy | $160 | ||
10/21/20 | Morgan Stanley | Maintained Buy | $165 | ||
10/12/20 | Jefferies & Company Inc. | Maintained Buy | $166 | ||
10/05/20 | Morgan Stanley | Maintained Buy | $158 |
Procter & Gamble Estimates* in USD
2022 | 2023 | 2024 | 2025 | 2026 | 2027 | |
---|---|---|---|---|---|---|
Revenue | 80,082 | 81,778 | 85,232 | 88,616 | 91,261 | - |
Dividend | 3.51 | 3.66 | 3.82 | 4.03 | 4.11 | - |
Dividend Yield (in %) | 2.40 % | 2.50 % | 2.61 % | 2.76 % | 2.81 % | - |
EPS | 5.82 | 5.93 | 6.40 | 6.92 | 7.47 | - |
P/E Ratio | 25.14 | 24.67 | 22.88 | 21.15 | 19.60 | - |
EBIT | 17,982 | 18,368 | 19,581 | 20,840 | 21,680 | - |
EBITDA | 20,853 | 21,347 | 22,668 | 24,241 | 25,531 | - |
Net Profit | 14,784 | 14,908 | 15,887 | 16,833 | 17,319 | - |
Net Profit Adjusted | 14,780 | 14,866 | 15,840 | 16,882 | 17,319 | - |
Pre-Tax Profit | 18,138 | 18,484 | 19,694 | 21,154 | 21,604 | - |
Net Profit (Adjusted) | 18,107 | 18,483 | 19,649 | 20,553 | 20,078 | - |
EPS (Non-GAAP) ex. SOE | 5.82 | 5.93 | 6.40 | 6.92 | 7.47 | - |
EPS (GAAP) | 5.84 | 5.95 | 6.41 | 6.92 | - | - |
Gross Income | 38,625 | 38,659 | 40,851 | 42,922 | - | - |
Cash Flow from Investing | -4,522 | -3,965 | -4,027 | -4,266 | - | - |
Cash Flow from Operations | 18,284 | 18,355 | 19,932 | 21,298 | - | - |
Cash Flow from Financing | -15,215 | -17,775 | -17,878 | -21,558 | - | - |
Cash Flow per Share | 6.36 | 6.80 | 7.59 | 7.61 | 5.93 | - |
Free Cash Flow | 14,647 | 14,330 | 15,740 | 17,118 | 18,487 | - |
Free Cash Flow per Share | 5.51 | 5.26 | 6.10 | - | - | - |
Book Value per Share | 19.39 | 20.20 | 26.33 | 30.30 | 22.66 | - |
Net Debt | 24,074 | 25,652 | 25,976 | 25,605 | 25,053 | - |
Research & Development Exp. | 2,264 | 2,255 | 2,341 | 2,688 | - | - |
Capital Expenditure | 3,479 | 3,915 | 3,920 | 3,988 | 3,935 | 4,237 |
Selling, General & Admin. Exp. | 20,378 | - | - | 21,701 | - | - |
Shareholder’s Equity | 46,576 | 47,528 | 47,091 | 44,982 | 49,049 | 51,152 |
Total Assets | 119,184 | 114,577 | 112,668 | 99,894 | - | - |
Previous Quarter | Current Quarter |
Next Quarter ending 12/31/22 |
Current Year ending 06/30/22 |
Next Year ending 06/30/23 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | - | - | 17 | 22 | 21 |
Average Estimate | - | - | 1.674 USD | 5.822 USD | 5.934 USD |
Year Ago | - | - | 1.660 USD | 5.660 USD | 5.822 USD |
Publish Date | - | - | 7/29/2022 | - | - |
Revenue Estimates | |||||
No. of Analysts | - | - | 13 | 19 | 18 |
Average Estimate | - | - | 21,263 USD | 80,082 USD | 81,778 USD |
Year Ago | - | - | 20,953 USD | 76,118 USD | 80,082 USD |
Publish Date | - | - | 7/29/2022 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Procter & Gamble Insider Activity
Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
---|---|---|---|---|---|---|
Coombe Gary A | 08/18/2022 | 12,930.00 | 29,488.90 | 149.21 | Sell | No |
Keith R. Alexandra | 08/17/2022 | 1,289.00 | 7,841.15 | 149.15 | Sell | No |
Keith R. Alexandra | 08/17/2022 | 17,347.00 | 35,213.06 | 148.92 | Sell | No |
Jejurikar Shailesh | 08/17/2022 | 18,981.00 | 279.29 | 148.87 | Sell | No |
Schulten Andre | 08/16/2022 | 987.00 | 27,330.34 | 149.33 | Sell | No |
Grabowski Mary Theresa | 08/16/2022 | 8,624.00 | 14,749.98 | 149.33 | Sell | No |
Moeller Jon R | 08/16/2022 | 29,405.00 | 201,223.78 | 149.33 | Sell | No |
Moeller Jon R | 08/16/2022 | 767.00 | 35,377.78 | 149.33 | Sell | No |
Whaley Susan Street | 08/16/2022 | 907.00 | 6,252.58 | 149.33 | Sell | No |
Raman Sundar G. | 08/16/2022 | 6,958.00 | 12,310.01 | 149.33 | Sell | No |
Pritchard Marc S. | 08/16/2022 | 12,228.00 | 154,158.05 | 149.33 | Sell | No |
Aguilar Moses Victor Javier | 08/16/2022 | 1,067.00 | 10,473.32 | 149.33 | Sell | No |
Keith R. Alexandra | 08/16/2022 | 1,080.00 | 9,130.15 | 149.33 | Sell | No |
Keith R. Alexandra | 08/16/2022 | 14,530.00 | 52,560.06 | 149.33 | Sell | No |
Francisco Ma. Fatima | 08/16/2022 | 12,252.00 | 17,331.13 | 149.33 | Sell | No |
Davis Jennifer L. | 08/16/2022 | 7,621.00 | 32,894.79 | 149.33 | Sell | No |
Jejurikar Shailesh | 08/16/2022 | 12,426.00 | 19,260.29 | 149.33 | Sell | No |
Francisco Ma. Fatima | 08/15/2022 | 58,538.00 | 1,025.51 | 149.50 | Sell | No |
Raman Sundar G. | 08/15/2022 | 5,000.00 | 4,004.01 | 150.00 | Sell | No |
Francisco Ma. Fatima | 08/15/2022 | 58,538.00 | 59,563.51 | 80.29 | Buy | No |
Schulten Andre | 08/15/2022 | 2,864.00 | 28,317.34 | n/a | Buy | No |
Grabowski Mary Theresa | 08/15/2022 | 19,021.00 | 23,373.98 | n/a | Buy | No |
Moeller Jon R | 08/15/2022 | 65,661.00 | 230,628.78 | n/a | Buy | No |
Moeller Jon R | 08/15/2022 | 1,712.00 | 36,144.78 | n/a | Buy | No |
Raman Sundar G. | 08/15/2022 | 15,264.00 | 19,268.01 | n/a | Buy | No |
Procter & Gamble Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2022 | Procter & Gamble Co. | 3.52 | 2.45 | USD |
2021 | Procter & Gamble Co. | 3.24 | 2.40 | USD |
2020 | Procter & Gamble Co. | 3.03 | 2.53 | USD |
2019 | Procter & Gamble Co. | 2.90 | 2.64 | USD |
2018 | Procter & Gamble Co. | 2.79 | 3.57 | USD |
2017 | Procter & Gamble Co. | 2.70 | 3.10 | USD |
2016 | Procter & Gamble Co. | 2.66 | 3.14 | USD |
2015 | Procter & Gamble Co. | 2.59 | 3.32 | USD |
2015 | Procter & Gamble Co. | 2.59 | 3.31 | USD |
2014 | Procter & Gamble Co. | 2.45 | 3.12 | USD |
2013 | Procter & Gamble Co. | 2.29 | 2.97 | USD |
2012 | Procter & Gamble Co. | 2.14 | 3.49 | USD |
2011 | Procter & Gamble Co. | 1.97 | 3.10 | USD |
2010 | Procter & Gamble Co. | 1.80 | 3.00 | USD |
2009 | Procter & Gamble Co. | 1.64 | 3.21 | USD |
2008 | Procter & Gamble Co. | 1.45 | 2.38 | USD |
2007 | Procter & Gamble Co. | 1.28 | 2.09 | USD |
2006 | Procter & Gamble Co. | 1.15 | 2.07 | USD |
2005 | Procter & Gamble Co. | 1.03 | 1.86 | USD |
2004 | Procter & Gamble Co. | 0.93 | 1.72 | USD |
2003 | Procter & Gamble Co. | 0.82 | 1.84 | USD |
2002 | Procter & Gamble Co. | 0.76 | 1.70 | USD |
2001 | Procter & Gamble Co. | 0.70 | 2.19 | USD |
2000 | Procter & Gamble Co. | 0.64 | 2.26 | USD |
1999 | Procter & Gamble Co. | 0.57 | 1.29 | USD |
*Yield of the Respective Date
Procter & Gamble Co. Calendar
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | - | Q1 2023 Earnings Release | 10/21/2022 |
Earnings Report | - | Q2 2023 Earnings Release | 01/18/2023 |
Earnings Report | - | Q3 2023 Earnings Release | 04/20/2023 |
Earnings Report | - | Q4 2023 Earnings Release | 07/28/2023 |
Procter & Gamble Co. Past Events
Event | Actual EPS | Info | Date |
---|---|---|---|
Press Conference | - | - | 07/29/2022 |
Earnings Report | 1.660 USD | Q4 2022 Earnings Release | 07/29/2022 |
Press Conference | - | - | 04/20/2022 |
Press Conference | - | - | 01/19/2022 |
Press Conference | - | - | 10/19/2021 |
Shareholders' Meeting | - | - | 10/12/2021 |
Procter & Gamble Stock Snapshot
145.81
Bid
26,400.00
Bid Size
145.82
Ask
34,200.00
Ask Size
8/24/2022
Date
4:15 PM
Time
2.09 M
Volume
146.45
Prev. Close
146.41
Open
357.15 B
Market Cap
2.39 B
Number of Shares
145.14
Day Low
147.26
Day High
145.82
129.50
52 Week Low
165.31
52 Week High
145.82
3.51
Dividend
2.40
Dividend Yield
24.68
P/E Ratio
99.91
Free Float in %
5.82
EPS 2022
19.39
Book Value per Share
6.36
Cash Flow per Share
Procter & Gamble Profile
Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper.
Moody’s Daily Credit Risk Score
Procter & Gamble Shareholder
Owner | in % |
---|---|
Freefloat | 99.91 |
The Vanguard Group, Inc. | 9.00 |
Vanguard Group, Inc. (Subfiler) | 8.89 |
State Street Corp. | 4.35 |
Vanguard Total Stock Market Index Fund | 2.96 |
BlackRock Fund Advisors | 2.51 |
Vanguard 500 Index Fund | 2.22 |
BlackRock Institutional Trust Co. NA | 2.17 |
Geode Capital Management LLC | 1.91 |
Wellington Management Co. LLP | 1.73 |
Northern Trust Corp. | 1.30 |
SPDR S&P 500 ETF Trust | 1.09 |
Fidelity 500 Index Fund | 1.07 |
Norges Bank (13F) | 0.95 |
Government Pension Fund - Global (The) | 0.93 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.
Procter & Gamble Management
Name | Job |
---|---|
Jon R. Moeller | Chairman, President & Chief Executive Officer |
Matthew W. Janzaruk | Chief Accounting Officer & Senior Vice President |
Kirti Singh | Chief Analytics & Insights Officer |
Marc S. Pritchard | Chief Brand Officer |
Damon Jones | Chief Communications Officer |
Philip J. Duncan | Chief Design Officer |
Shelly McNamara | Chief Equality & Inclusion Officer |
Ken K. Patel | Chief Ethics & Compliance Officer |
Fatima Francisco | Chief Executive Officer-Baby & Feminine Care |
R. Alexandra Keith | Chief Executive Officer-Beauty |
Carolyn M. Tastad | Chief Executive Officer-Health Care |
Andre Schulten | Chief Financial Officer |
Mary Theresa Grabowski | Chief Human Resources Officer |
Vittorio Cretella | Chief Information Officer |
Shailesh G. Jejurikar | Chief Operating Officer |
Julio N. Nemeth | Chief Product Supply Officer |
Victor Aguilar | Chief Research, Development & Innovation Officer |
Mindy Sherwood | Chief Sales Officer & President-Global Walmart |
Virginie Helias | Chief Sustainability Officer |
Christopher J. Kempczinski | Director |
Debra L. Lee | Independent Director |
Terry J. Lundgren | Independent Director |
Margaret Cushing Whitman | Independent Director |
Angela F. Braly | Independent Director |
Bertrand-Marc Allen | Independent Director |
Patricia Ann Woertz | Independent Director |
Amy L. Chang | Independent Director |
Christine M. McCarthy | Independent Director |
Joseph Jimenez | Independent Director |
John T. Chevalier | Investor Relations Contact |
Ivy Ross | Member-Design Board |
Magesvaran Suranjan | President-Asia Pacific Selling & Market Operations |
Deborah Platt Majoras | Secretary & Chief Legal Officer |
Namrata P Patel | Senior Vice President-Product Supply |